Eton Pharmaceuticals (ETON) Non-Current Assets (2017 - 2026)
Eton Pharmaceuticals (ETON) recorded Non-Current Assets of $47.21 million in Q2 2026, up 42.1% from $33.23 million a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Eton Pharmaceuticals reported Non-Current Assets of $31.53 million, down 10.2% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 81.1% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $35.1 million in FY2024 (+616.2%), $4.9 million in FY2023 (-2.5%), $5.03 million in FY2022 (+30.2%) and $3.86 million in FY2021 (+138.6%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2017.
- On a year-over-year basis, Non-Current Assets rose in six of the last seven quarters, with growth averaging 280.4%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 616.2% in Q4 2024, against a decline of 53.9% in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Eton Pharmaceuticals | 1.36 Bn | 1.24 Bn | 25.41 Mn | 47.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.21 Mn |
| Dec 31, 2025 | 31.53 Mn |
| Sep 30, 2025 | 32.51 Mn |
| Jun 30, 2025 | 33.23 Mn |
| Mar 31, 2025 | 34.07 Mn |
| Dec 31, 2024 | 35.10 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 6.39 Mn |
| Mar 31, 2024 | 6.53 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 5.03 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 3.27 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 3.86 Mn |
| Sep 30, 2021 | 743,000.00 |
| Jun 30, 2021 | 831,000.00 |
API Access
Eton Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();